THE USE OF ANTISEPTICS BASED ON POLYHEXAMETHYLENE BIGUANIDE FOR THE TREATMENT OF WOUND INFECTION

The article is about the fact that 15 years ago Belarusian scientists created an antiseptic drug for prevention and treatment of wound infection on the basis of polyhexamethylene biguanide – «Mukosanin», and nowadays the use of such medications has become a worldwide trend in wound infection.

1. Mezhdisciplinarnaya ekspertnaya rekomendaciya «Konsensus po antiseptike ran» odobrena sleduyushchimi ekspertnymi organami: rabochaya gruppa po antiseptikam Mezhdunarodnogo obshchestva himioterapii pri infekciyah i rake (ISC), nemeckoe obshchestvo gigieny bol’nic (DGKH), iniciativa po hronicheskim ranam (ICW), avstrijskoe obshchestvo gigieny bol’nic (ÖGKH), Wund-D.A.CH (Zontichnaya organizaciya vsekh nemeckoyazychnyh associacij i grupp v oblasti uhoda za ranami). https://www.woundsinternational.com/resources/details/wound-infection-in-clinical-practice-principles of-best-practice

2. Primenenie antisepticheskih lekarstvennyh sredstv v zdravoohranenii na fone rezistentnosti mikroorganizmov k antibiotikam i sovremennaya innovacionnaya razrabotka kompanii «BelAseptika» – «Mukosanin». https://belaseptika.by/know/the-use-of-antisepticdrugs-in-health-care-against-the-background-of-resistance-of-microorganisms-to/

3. Rukovodstvo 2022 «Ranevye infekcii v klinicheskoj praktike. Principy peredovoj praktiki», opublikovannoe Mezhdunarodnym institutom ranevyh infekcij v zhurnale Wounds Group. https://www.researchgate.net/publication/321975759_Consensus_on_Wound_Antisepsis_Update_2018